These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21738504)

  • 21. Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma.
    Ueda T; Murata S; Yasui D; Mine T; Kumita S
    Hepatol Res; 2013 Oct; 43(10):1071-7. PubMed ID: 23905645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of curative resection for advanced hepatocellular carcinoma with portal vein tumor thrombus after hepatic arterial infusion chemotherapy].
    Ishizaki M; Kaibori M; Matsui K; Nakatake R; Matsushima H; Sakaguchi T; Kwon AH
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1991-3. PubMed ID: 23267953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib].
    Endo Y; Miyamoto M; Koujima T; Watanabe Y; Kawai T; Toda K; Nobuhisa T; Watanabe T; Matsumoto Y; Watanabe N; Kai K; Sato S
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):963-5. PubMed ID: 22705693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
    Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil
    Lee SW; Lee HL; Han NI; Kwon JH; Nam SW; Jang JW; Bae SH; Choi JY; Yoon SK
    Ther Adv Med Oncol; 2017 Oct; 9(10):615-626. PubMed ID: 28974984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Imai Y; Chikayama T; Nakazawa M; Watanabe K; Ando S; Mizuno Y; Yoshino K; Sugawara K; Hamaoka K; Fujimori K; Inao M; Nakayama N; Oka M; Nagoshi S; Mochida S
    J Gastroenterol; 2012 Feb; 47(2):179-86. PubMed ID: 21976133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
    Miyamoto N; Kanaya M; Fujii T; Kato H; Kudo K; Kinota N
    Jpn J Radiol; 2021 Apr; 39(4):376-386. PubMed ID: 33150469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
    Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
    Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.
    Ishikawa T; Imai M; Kamimura H; Tsuchiya A; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
    World J Gastroenterol; 2007 Nov; 13(41):5465-70. PubMed ID: 17907289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective accumulation of platinum and formation of platinum-DNA adducts in hepatocellular carcinoma after transarterial chemoembolization with miriplatin.
    Yasui K; Takashima H; Miyagawa M; Miyazawa K; Ochiai T; Mukaisho K; Amaike H; Ueda K; Morikawa J; Otsuji E; Yoshikawa T
    Hepatol Res; 2013 Oct; 43(10):1093-9. PubMed ID: 23347452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats.
    Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T
    Cancer Sci; 2009 Jan; 100(1):189-94. PubMed ID: 19037997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Aramaki T; Moriguchi M; Bekku E; Asakura K; Sawada A; Endo M
    Hepatol Res; 2013 May; 43(5):475-80. PubMed ID: 23046493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of successful treatment with intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus].
    Mukai Y; Takeda Y; Nakahira S; Kawashima H; Hamanaka M; Uchiyama C; Kanemura T; Takeno A; Okishiro M; Suzuki R; Egawa C; Taniguchi H; Nakata K; Miki H; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1815-8. PubMed ID: 23267896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases.
    Ogawa K; Kamimura K; Watanabe Y; Motai Y; Kumaki D; Seki R; Sakamaki A; Abe S; Kawai H; Suda T; Yamagiwa S; Terai S
    World J Clin Cases; 2017 Jun; 5(6):238-246. PubMed ID: 28685137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report.
    Chen X; Liu L; Pan X
    Oncol Lett; 2015 Jun; 9(6):2495-2498. PubMed ID: 26137096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Three (3) cases of advanced hepatocellular carcinoma (HCC) treated successfully by transcatheter arterial chemoembolization (TACE) using lipiodol and a fine- powder formulated cisplatin (DH)].
    Kasai K; Kuroda H; Ushio A; Miyamoto Y; Sawara K; Miyasaka A; Takikawa Y; Suzuki K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):479-83. PubMed ID: 19295276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
    Masutani S; Shimizu J; Tatsuta M; Katoh H; Kitani K; Esumi K; Masuda N; Imamura H; Ishida H; Furukawa H; Onishi H; Tsuda K; Inoue Y; Tomotsu K; Usui T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2378-81. PubMed ID: 12484079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.